Non-Current Assets
Total Assets
Bristol-Myers Squibb Total Assets increased by 2.3% to $96.89B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $93.67B to $96.89B. Over 4 years (FY 2020 to FY 2024), Total Assets shows a downward trend with a -6.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Growth in total assets typically mirrors the overall expansion of the business, provided it is accompanied by corresponding revenue growth.
Detailed definition
The aggregate value of everything the company owns, including both short-term liquid resources and long-term physical an...
Peer comparison
Used to compare the scale of operations across the industry; larger asset bases generally suggest a more dominant market presence.
Metric ID:
total_assetsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $110.80B | $110.89B | $109.31B | $103.03B | $100.36B | $98.20B | $96.82B | $94.28B | $93.49B | $91.26B | $95.16B | $99.03B | $94.65B | $93.67B | $92.60B | $92.43B | $94.68B | $96.89B |
| QoQ Change | — | +0.1% | -1.4% | -5.7% | -2.6% | -2.2% | -1.4% | -2.6% | -0.8% | -2.4% | +4.3% | +4.1% | -4.4% | -1.0% | -1.1% | -0.2% | +2.4% | +2.3% |
| YoY Change | — | — | — | — | -9.4% | -11.4% | -11.4% | -8.5% | -6.8% | -7.1% | -1.7% | +5.0% | +1.2% | +2.6% | -2.7% | -6.7% | +0.0% | +3.4% |
Range$91.26B – $110.89B
CAGR-3.1%
Avg YoY Growth-3.8%
Median YoY Growth-4.7%
Current Streak2 quarters growth
Total Assets at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total assets?
- Bristol-Myers Squibb (BMY) reported total assets of $96.89B in Q3 2025.
- How has Bristol-Myers Squibb's total assets changed year-over-year?
- Bristol-Myers Squibb's total assets increased by 3.4% year-over-year, from $93.67B to $96.89B.
- What is the long-term trend for Bristol-Myers Squibb's total assets?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's total assets has grown at a -6.0% compound annual growth rate (CAGR), from $118.48B to $92.60B.
- What does total assets mean?
- The total value of everything the company owns, from cash to buildings.